Ch. 20 Postmenopausal Sono & Sonohysterography Flashcards
Cessation of menstruation with advanced age, median age of 51 (42-58)
menopause (climacteric)
During menopause follicles cease to mature resulting in a considerable reduction in the amounts of ___ & ___.
estrogen, progesterone
Without menstruation what happens to the ovaries and uterus?
undergoes atrophy, ovaries become more echogenic, Along with the decrease in uterine size, the mucosal layer of the uterus—the endometrium—begins to become atrophic as menstruation comes to an end.
Menopause puts women at an increased risk for developing?
coronary heart disease, osteopenia (bone density that is lower than normal), osteoporosis (bone loss that predisposes the individual to fractures)
Often used to combat the reduction of estrogen circulating in the female body after menopause and prevent their symptoms is called
hormone replacement therapy (HRT)
has been shown to significantly reduce the risk of developing osteoporosis and coronary heart disease, with possible associated reduction in risk for developing colon cancer and Alzheimer disease.
Estrogen replacement therapy (ERT)
___ exposure on the endometrium increase the risk for endometrial hyperplasia, endometrial carcinoma.There may also be an increased risk of developing breast cancer, thromboembolism, hypertension, and, possibly, diabetes in patients who are on _____.
unopposed estrogen; ERT
Before performing a postmenopausal pelvic sonogram it is vital to inquire if the patient is on what because it influence the appearance of the endometrium?
hormone replacement therapy (HRT)
The vagina also becomes smaller and decreases in caliber. The breasts tend to accumulate more adipose or fat tissue within them. Patients undergoing menopause may also suffer from night sweats or hot flashes, mood changes, depression, dyspareunia, dysuria, and a decrease in libido. Pts undergoing this are in what?
Menopause
These hormones, when used in conjunction, act upon the endometrium and in effect induce a menstrual cycle. Combined________, when used consistently, can reduce the risk of developing endometrial carcinoma but cannot eliminate it entirely.
Estrogen-progestin therapy
The most common cause of PMB(postmenopausal bleeding) is _______.
endometrial atrophy
Endometrial atrophy (59%), uncontrolled HRT, endometrial hyperplasia (10%), endometrial polyps (9%), submucosal or intracavitary leiomyoma, endometrial carcinoma (5% to 10%), and some ovarian tumors are among the differential abnormalities that can be linked to ______
PMB
double-layer thickness
Normal Endometrial Thickness:(mm)Positive postmenopausal vaginal bleeding_____
≤4
Normal Endometrial Thickness:
Negative postmenopausal vaginal bleeding_____
≤8
Endometrial thickness threshold of ___ is used for patients with postmenopausal vaginal bleeding (PMB).
4-5mm
If the endometrium measures less than 5 mm, the bleeding is typically caused by ______
endometrial atrophy
The endometrium will appear thin and should not exceed 5 mm, although, with ______, the endometrium typically measures 4 mm or thinner. The endometrium may also contain some intracavitary fluid.
atrophy
Results from the unopposed stimulation of estrogen on the endometrium and is a common cause of abnormal vaginal bleeding
endometrial hyperplasia ( an increase in the number of endometrial cells)
_______may also be caused by polycystic ovary syndrome, obesity, tamoxifen therapy for breast cancer, or estrogen-producing ovarian tumors, such as the ovarian thecoma or granulosa cell tumor.
Endometrial hyperplasia
benign ovarian sex cord-stromal tumor that produces estrogen in older women
thecoma